Down and High: Reflections Regarding Depression and Cannabis
- PMID: 34054594
- PMCID: PMC8160288
- DOI: 10.3389/fpsyt.2021.625158
Down and High: Reflections Regarding Depression and Cannabis
Abstract
In light of the recent changes in the legal status of cannabis in Canada, the understanding of the potential impact of the use of cannabis by individuals suffering from depression is increasingly considered as being important. It is fundamental that we look into the existing literature to examine the influence of cannabis on psychiatric conditions, including mood disorders. In this article, we will explore the relationship that exists between depression and cannabis. We will examine the impact of cannabis on the onset and course of depression, and its treatment. We have undertaken a wide-ranging review of the literature in order to address these questions. The evidence from longitudinal studies suggest that there is a bidirectional relationship between cannabis use and depression, such that cannabis use increases the risk for depression and vice-versa. This risk is possibly higher in heavy users having initiated their consumption in early adolescence. Clinical evidence also suggests that cannabis use is associated with a worse prognosis in individuals with major depressive disorder. The link with suicide remains controversial. Moreover, there is insufficient data to determine the impact of cannabis use on cognition in individuals with major depression disorder. Preliminary evidence suggesting that the endogenous cannabinoid system is involved in the pathophysiology of depression. This will need to be confirmed in future positron emission tomography studies. Randomized controlled trials are needed to investigate the potential efficacy of motivational interviewing and/or cognitive behavioral therapy for the treatment of cannabis use disorder in individuals with major depressive major disorder. Finally, although there is preclinical evidence suggesting that cannabidiol has antidepressant properties, randomized controlled trials will need to properly investigate this possibility in humans.
Keywords: cannabis; depression; epidemiology; impact; legalization; mechanisms of action.
Copyright © 2021 Langlois, Potvin, Khullar and Tourjman.
Conflict of interest statement
AK has consulted with Spectrum Therapeutics and Tilray in an advisory, mentorship and educational role. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.Turk Psikiyatri Derg. 2021;32(4):293-295. doi: 10.5080/u26899. Turk Psikiyatri Derg. 2021. PMID: 34964106 English, Turkish.
-
[Motivational interviewing for cannabis users with psychotic disorders].Encephale. 2007 Oct;33(5):819-26. doi: 10.1016/j.encep.2006.08.001. Encephale. 2007. PMID: 18357854 French.
-
Cannabis Use and the Risk for Psychosis and Affective Disorders.J Dual Diagn. 2020 Jan-Mar;16(1):22-42. doi: 10.1080/15504263.2019.1674991. Epub 2019 Oct 24. J Dual Diagn. 2020. PMID: 31647377 Review.
-
Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review.Int J Environ Res Public Health. 2022 Jan 4;19(1):523. doi: 10.3390/ijerph19010523. Int J Environ Res Public Health. 2022. PMID: 35010782 Free PMC article. Review.
-
Exploring the association between cannabis use and depression.Addiction. 2003 Nov;98(11):1493-504. doi: 10.1046/j.1360-0443.2003.00437.x. Addiction. 2003. PMID: 14616175 Review.
Cited by
-
Mental Health and Dispositional Predictors of Simultaneous Versus Concurrent Cannabis and Alcohol Use in a Canadian Context.Cannabis. 2024 Dec 12;7(3):41-60. doi: 10.26828/cannabis/2024/000256. eCollection 2024. Cannabis. 2024. PMID: 39781556 Free PMC article.
-
Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants.J Neurovirol. 2024 Dec;30(5-6):500-512. doi: 10.1007/s13365-024-01225-8. Epub 2024 Aug 12. J Neurovirol. 2024. PMID: 39134913
-
Youth cannabis use in Canada post-legalization: service providers' perceptions, practices, and recommendations.Subst Abuse Treat Prev Policy. 2023 Jun 22;18(1):36. doi: 10.1186/s13011-023-00550-1. Subst Abuse Treat Prev Policy. 2023. PMID: 37349741 Free PMC article.
-
Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue.Subst Abuse Treat Prev Policy. 2024 Jun 17;19(1):30. doi: 10.1186/s13011-024-00615-9. Subst Abuse Treat Prev Policy. 2024. PMID: 38886804 Free PMC article.
-
Unhealthy behaviors associated with mental health disorders: a systematic comparative review of diet quality, sedentary behavior, and cannabis and tobacco use.Front Public Health. 2024 Jan 5;11:1268339. doi: 10.3389/fpubh.2023.1268339. eCollection 2023. Front Public Health. 2024. PMID: 38249418 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources